A5050181658- COVID-19 and Mental Health
- Long-Term Effects of COVID-19
- Urinary Tract Infections Management
- Reproductive tract infections research
- Psychosomatic Disorders and Their Treatments
- Fibromyalgia and Chronic Fatigue Syndrome Research
- Bacterial Identification and Susceptibility Testing
This study assessed symptoms and their determinants 1.5–6 months after symptom onset in non-hospitalised subjects with confirmed COVID-19 until 1 June 2020, a geographically defined area. We invited 938 subjects; 451 (48%) responded. They reported less than during COVID-19; median (IQR) 0 (0–2) versus 8 (6–11), respectively (p<0.001); 53% of women 67% men were free, while 16% dyspnoea, 12% loss/disturbance smell, 10% taste. In multivariable analysis, having persistent was associated the...
This study assessed the prevalence and determinants of fatigue in a population-based cohort non-hospitalized subjects 1.5–6 months after COVID-19. It was mixed postal/web survey all patients ≥18 years with positive PCR for SARS-CoV-2 until 1 June 2020 geographically defined area. In total, 938 received questionnaire including Chalder scale (CFQ-11) energy/fatigue RAND-36 questionnaire. We estimated z scores comparison general population norms. Determinants were analyzed using multivariable...
Background We evaluated if flowcytometry, using Sysmex UF-5000, could improve diagnosis of urinary tract infections by rapid identification culture negative and contaminated samples prior to plating, thus reducing plating workload response time. also it is possible reduce the time for antibiotic susceptibility profiles bacteria information flag on UF-5000 differentiate between Gram positive bacteria, followed direct Antibiotic Susceptibility Testing (dAST) urine samples. Methods One thousand...